A claims data sample from Express Scripts shows that patients enrolling for health coverage under the Affordable Care Act (ACA) are more likely to use specialty drugs to treat HIV/AIDS or hepatitis C than those with coverage through employers. The results, which cover claims from the first 2 months of 2014, were reported April 9, 2014, by MedCity News.1
Experts noted that the results do not reflect late enrollment that caused the ranks signing up on state and federal exchanges to swell past 7 million, the original target for ACA enrollment from the Congressional Budget Office. Enrollment on the exchanges through the end of January was only 3.3 million, as reported by the US Department of Health and Human Services.2
It was no surprise that those with chronic conditions enrolled as early as possible, with younger, healthier consumers signing up closer to the deadline. “We all expected that the people who signed up by January and February would be a lot sicker than anyone else,” said Robert Lazsewski, a consultant to the insurance industry. “It will be a year before we know what we’ve got.”1
Express Scripts, one of the nation’s largest pharmacy benefit managers, analyzed more than 650,000 claims filed in January and February with 25 insurers, and compared them to claims filed by a subset of employer-based plans that Express Scripts oversees.
The analysis was based on total drug spending, including the portion paid by insurers and patients. Among the findings:
• HIV drugs accounted for more than 6 in every 1000 prescriptions, a rate 4 times that of employer plans.
• Sovaldi, an $84,000 treatment approved in December to treat hepatitis C, came in second for total spending, while it ranked eighth in the comparison group.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More